Preparing for China · patient guide

Tumor board review in China: what to prepare

Prepare for a tumor board review in China by assembling the evidence the panel needs to reason with: representative pathology slides or blocks with the original report, imaging in reviewable digital form, a dated treatment history, current medication and comorbidity information, and one clear question. The board interprets records; it does not examine you, so missing material limits what it can conclude. The hospital decides whether a review is appropriate.

Go to the practical guidance ↓
AI illustration: A doctor discusses with a patient in a consultation room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a tumor board actually does with your file

A tumor board, or multidisciplinary team meeting, is a scheduled discussion in which clinicians from different specialties look at the same case together. For a solid tumor that may mean surgery, medical oncology, radiation oncology, radiology and pathology represented in one conversation. The purpose is to reconcile evidence that is usually scattered across separate appointments: what the pathology shows, what the imaging shows, what treatment has already been given, and what the patient's overall health allows.

Understanding this shapes your preparation. The panel does not meet you in the room during the discussion. It works from documents, images and reports, plus whatever summary the referring clinician provides. A board can clarify the nature of a lesion, question whether the diagnosis is complete, compare reasonable treatment sequences, or identify what further information is needed before a recommendation makes sense. It cannot confirm how you look or feel today, and it cannot replace a physical consultation with the clinician who will actually treat you.

That is why the quality of a review depends less on how many pages you send than on whether the key evidence is present and legible. A thin file produces a cautious, hedged opinion. A well-organised file lets the panel reach a specific discussion. The practical goal of your preparation is to remove every avoidable gap before the meeting.

One more boundary matters. A records-based multidisciplinary opinion is advice, not hospital acceptance and not a guaranteed treatment plan. Suitability for any operation, drug regimen or radiotherapy course is decided by the treating team after they have assessed you. Treat the board output as a structured second opinion that informs your next decision, whether that decision is made in China or at home.

The pathology material is the foundation

If the diagnosis rests on a tissue sample, the pathology is the single most important thing to send. A written pathology report alone is often not enough, because a reviewing pathologist may need to look at the actual slides, and sometimes at the stored tissue block, to confirm the tumor type, grade or other features. Ask your treating hospital or laboratory what it can release and in what form.

The original report should travel with the material, including any addendum, immunohistochemistry panel, molecular or genomic results, and the date of the specimen. If a biopsy was repeated or taken at a second site, send both. If a prior diagnosis was revised, include the revision. Reviewers need the sequence, not just the final line.

Cross-border transport of biological material involves rules that vary by country and by carrier, and some material cannot leave the country where it was taken. Do not assume slides can simply be posted. Ask the laboratory that holds them what export documentation or permissions apply, and ask the receiving hospital in China what it will accept and in what format. Where physical material cannot travel, a digital pathology image may be an alternative, but whether the receiving pathologist considers it adequate is their judgement.

If you have already had a pathology review elsewhere, include it. A second reviewer benefits from knowing what a previous reviewer concluded and on what basis. Do not edit or summarise away disagreements; the board needs to see them.

Cancer pathology review

Imaging that a radiologist can actually read

Reports describe images; they do not replace them. A radiologist reviewing your case will want the original image data, not only the typed report, so that measurements, staging and comparison over time can be assessed directly. Ask the imaging facility for the images in a standard digital format on disc or through a secure link, together with the written reports.

Send the relevant studies across time, not only the most recent. A single scan shows the current state; a series shows whether something is growing, stable or responding. Include the study dates clearly. If a scan was performed at a different hospital, obtain that study too, because the comparison may be the most informative part of the file.

Imaging formats and viewing software differ between hospitals. Ask the receiving hospital whether it can open the format you have and whether it needs the images uploaded in a particular way before your appointment. This is an administrative question with a clinical consequence: if the images cannot be opened, the review is limited to the report.

Do not arrange new imaging solely to satisfy a review before you have asked whether it is needed. The treating clinicians decide which investigations are appropriate, and repeating a test that was recently done elsewhere may add nothing. Ask what is missing from your existing file first.

A treatment history the panel can follow

Write a chronological summary of your cancer care to date. For each treatment, record what was given, when it started and stopped, and why it changed. Include surgery with dates and operative findings, radiotherapy with the site and course, and systemic therapy by drug name rather than brand alone. If treatment was interrupted for toxicity or another reason, say so.

Attach the supporting documents behind the summary: discharge summaries, operation notes, chemotherapy and radiotherapy records, and the most recent clinic letters. A concise summary at the front helps the panel orient quickly, but the underlying documents must be there for verification.

Include current medications, allergies, other significant medical conditions and relevant blood results. These shape what a board considers feasible. A recommendation that ignores kidney function, cardiac history or frailty is not useful, and the panel can only account for these if they are in the file.

State your own priorities plainly. Some patients want the most aggressive option available; others want to protect function, avoid a long admission, or understand whether a period of observation is reasonable. A board that knows the patient's goal can weigh options differently. Put this in one or two sentences rather than a long narrative.

Framing the question you want answered

A vague request such as "please advise on treatment" gives the panel little to work with. A focused question produces a focused answer. Good questions name the decision point: whether the diagnosis is secure, whether surgery is technically and oncologically appropriate, whether the sequence of local and systemic treatment should change, or whether the current plan remains reasonable given new information.

Write down two or three questions at most, in order of importance. If you have been offered a plan at home and want a second view, say what that plan is and what specifically concerns you. If you are seeking care in China, say so, because the board may frame its advice around what can be delivered locally, while noting that availability and eligibility still require confirmation.

Be honest about uncertainty. If a report is ambiguous, if a test result is pending, or if you do not understand part of your history, say that. Reviewers can work with acknowledged gaps; they cannot correct a gap they do not know exists.

Finally, decide in advance who will receive and interpret the board's conclusion. A written opinion in a second language, or one that uses unfamiliar terminology, is easy to misread. Ask how the conclusion will be explained to you and whether you can ask follow-up questions about it.

Practical arrangements and what remains the hospital's decision

Ask the hospital, before anything is sent, what it needs, in what format, and through which channel. Records containing personal health information should travel by a route the hospital confirms as secure. Do not send passport numbers, payment details or a complete archive in a first message; begin with a short summary and let the provider tell you what to add.

Clarify the administrative shape of the review. Is it a meeting of the hospital's own multidisciplinary team, or a smaller records-based opinion from one or two specialists? Who will write the conclusion, and in what language? What is the fee for the review, and is it separate from any later consultation, test or treatment charge? These are questions for the named provider, and the answers should be in writing.

Keep expectations calibrated. A board review can sharpen a decision, identify a missing test, or confirm that a proposed plan is reasonable. It cannot establish that a particular therapy is available to you, that a clinical trial will accept you, or that a transplant or advanced therapy is accessible. Those determinations belong to the relevant programme and its own eligibility process.

If your symptoms worsen while arrangements are underway, seek local medical assessment rather than waiting for the review. A scheduled discussion is not an emergency route.

A realistic next step

Start by gathering the pathology report and material status, the imaging in digital form with reports, and a dated treatment summary. Then send a short outline of your case and your main question. ChinaSpecialistCare's team can check what you have, point out obvious gaps and suggest a relevant next step; this initial review is free and is not a diagnosis or a promise of acceptance. A proxy consultation, in which records are taken to a specialist while you remain at home, is optional rather than a prerequisite. The treating hospital decides whether a tumor board review is appropriate for your case and what it can conclude from the records you provide.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. radiotherapy
  2. Cancer pathology review

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.